This article first appeared on GuruFocus. UiPath (NYSE:PATH) shares surged more than 8% on early Thursday after the company topped expectations with its third-quarter results and gave upbeat guidance.

A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history.

Oct 24 (Reuters) - European rating agency Scope downgraded the United States' credit rating by a notch on Friday, citing sustained deterioration in public finances and a weakening of governance ...

UiPath Inc. (NYSE:PATH) saw its stock rise 7.70% in pre-market trading on Thursday, reaching $16.79. Check out the current price of PATH stock here. The automation software company added $1.12 per ...

UiPath stock rallied after announcing several new partnerships. The company is looking to reinvent itself as an agentic automation company. The stock is cheap and could have nice upside if these ...

UiPath agreed to a partnership with OpenAI to simplify and advance AI agent development for business. The agentic automation company said in collaboration with OpenAI, it would build a ChatGPT ...

UiPath Inc. raised its full-year revenue outlook after cruising past Wall Street’s expectations and swinging to a profit in its latest quarterly results, powered by momentum in its artificial ...

If your Excel spreadsheet always opens in a small window and not a maximized one, follow these steps to resolve the issue: You can resize your Excel windows by using these methods: Method 1: You can ...

Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] by Lisa Stiffler on Aug 25, 2025 at 12:36 pm August 25, 2025 at 1:31 ...

Please provide your email address to receive an email when new articles are posted on . This is the first biologics license application submitted for a gene-agnostic retinal disease gene therapy.